Imagine trying treatment after treatment for depression, and nothing seems to work. This is the reality of treatment-resistant depression, and it leaves people searching for new approaches. A recent review looked at a novel idea: combining two different therapies that target the brain in complementary ways. The first is repetitive Transcranial Magnetic Stimulation (rTMS), a non-invasive procedure that uses magnetic pulses to stimulate specific brain areas. The second is Mindfulness-Based Interventions (MBI), which are training programs that teach skills for managing thoughts and emotions. The theory is that while rTMS might help 'reset' certain brain circuits, mindfulness could help a person build the mental skills to maintain those changes, potentially leading to stronger and more lasting relief. The authors propose this combination could enhance outcomes through what they call 'synergistic effects' on brain network reorganization. It's important to understand what this review is and isn't. It didn't test this combination in people. Instead, it looked at the separate evidence for each therapy and the theoretical reasons why putting them together makes biological sense. The authors themselves note the evidence is limited, relying on theories about how the brain works and lessons from other, similar treatment pairings. No new safety information is reported here, as this is a theoretical proposal. The real value of this work is that it lays out a clear, science-backed rationale for why researchers should design and run clinical trials to test this specific combination in people who need more help.
Could combining brain stimulation with mindfulness help stubborn depression?
Photo by ClinicalPulse / Unsplash
What this means for you:
A theory, not a treatment: combining TMS and mindfulness for depression needs real-world testing. More on Treatment-Resistant Depression
SCC DBS with at-home LFP data collection predicts stable recovery in treatment-resistant depression. New brain signal predicts stable recovery for depression patients at home.
medRxiv · Apr 22, 2026
Intensive Short-Term Dynamic Psychotherapy showed large effects on depression in treatment-resistant depression patients. New Therapy Shifts How We Treat Stubborn Depression
Frontiers · Apr 22, 2026
Narrative review of TRD epidemiology and CYP2C19 genotypes in Pakistan New Clue Reveals Why Depression Meds Fail Some People
medRxiv · Apr 19, 2026
Narrative review links ceramide elevations to major depressive disorder and suicidal vulnerability. Fatty Acids in Blood May Signal Depression Risk
Frontiers · Apr 18, 2026